Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant SARS-CoV-2 Spike antibody (RBD)

This Cynomolgus Monkey (Macaca fascicularis) Chimeric antibody specifically detects SARS-CoV-2 Spike in ELISA, Neut and SR. It exhibits reactivity toward SARS Coronavirus-2 (SARS-CoV-2).
Catalog No. ABIN7271731

Quick Overview for Recombinant SARS-CoV-2 Spike antibody (RBD) (ABIN7271731)

Target

See all SARS-CoV-2 Spike Antibodies
SARS-CoV-2 Spike

Antibody Type

Recombinant Antibody

Reactivity

  • 120
  • 7
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
SARS Coronavirus-2 (SARS-CoV-2)

Host

  • 54
  • 31
  • 31
  • 3
  • 2
  • 1
  • 1
  • 1
Cynomolgus Monkey (Macaca fascicularis)

Clonality

  • 93
  • 18
  • 10
Chimeric

Conjugate

  • 98
  • 18
  • 3
  • 1
  • 1
This SARS-CoV-2 Spike antibody is un-conjugated

Application

  • 100
  • 54
  • 24
  • 14
  • 10
  • 7
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
ELISA, Neutralization (Neut), Spike and Recovery (SR)

Clone

AM122
  • Binding Specificity

    • 63
    • 11
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    RBD

    Purpose

    Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Cynomolgus IgG1 (AM122)

    Specificity

    This product is a specific antibody against SARS-CoV-2 Spike protein RBD domain. No cross-reactivity is detected with Spike protein RBD domain of other coronaviruses, including SARS-CoV, MERS-CoV, HCoV-229E, HCoV-NL63, HCoV-OC43 and HCoV-HKU1.

    Characteristics

    Recombinant Antibodies produced in HEK293. Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Cynomolgus IgG1 (AM122) is a chimeric monoclonal antibody recombinantly expressed from HEK293 cells, which combines the variable region of a mouse monoclonal antibody with Cynomolgus IgG1 constant domain. The mouse monoclonal antibody was obtained from a mouse immunized with recombinant SARS-CoV-2 Spike S1 Protein.

    Immunogen

    Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Cynomolgus IgG1 (AM122) (ABIN7271731 and ABIN7273320) is a chimeric monoclonal antibody recombinantly expressed from HEK293 cells, which combines the variable region of a mouse monoclonal antibody with Cynomolgus IgG1 constant domain. The mouse monoclonal antibody was obtained from a mouse immunized with recombinant SARS-CoV-2 Spike S1 Protein.

    Isotype

    IgG1
  • Application Notes

    This antibody can be paired with other Anti-SARS-CoV-2 Spike S1 antibodies to detect SARS-CoV-2 Spike S1 protein in sandwich ELISA or LFA assay.

    Restrictions

    For Research Use only
  • Format

    Powder

    Storage

    -20 °C

    Storage Comment

    -20°C
  • Target

    SARS-CoV-2 Spike

    Background

    It's been reported that Coronavirus can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.
You are here:
Chat with us!